Cargando…
COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
BACKGROUND: The mayhem COVID-19 that was ushered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) was declared pandemic by the World Health Organization in March 2020. Since its initial outbreak in late 2019, the virus has affected hundreds of million adults in the world and killin...
Autores principales: | Biswas, Biswajit, Chattopadhyay, Shagnik, Hazra, Sayantee, Hansda, Arman Kunwar, Goswami, Ritobrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923340/ https://www.ncbi.nlm.nih.gov/pubmed/35292834 http://dx.doi.org/10.1007/s00011-022-01555-5 |
Ejemplares similares
-
IL-10/IL-6 ratio from nasal & oral swab samples, acts as an inflammatory indicator for COVID-19 patients infected with the delta variant
por: Biswas, Biswajit, et al.
Publicado: (2023) -
Prediction of vaccine efficacy of the Delta variant
por: Chen, Xinhua, et al.
Publicado: (2021) -
Editorial: T Cell Differentiation and Function in Tissue Inflammation
por: Goswami, Ritobrata, et al.
Publicado: (2020) -
The challenges of COVID‐19 Delta variant: Prevention and vaccine development
por: He, Xuemei, et al.
Publicado: (2021) -
A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease
por: Vyas, Shachi Pranjal, et al.
Publicado: (2018)